SEER Q3 2022 Earnings — Seer, Inc. Revenue & Financial Results | Market Cap Arena

SEERSeer, Inc.

$98M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+84.4% YoY

Gross Profit

$882,00022.3% margin

Operating Income

-$25M-633.8% margin

Net Income

-$24M-606.3% margin

EPS (Diluted)

$-0.37

QoQ Revenue Growth

+9.2%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$16M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$500M

Total Liabilities

$42M

Stockholders' Equity

$458M

Cash & Equivalents

$68M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$2M	+84.4%
Gross Profit	$882,000	$479,000	+84.1%
Operating Income	-$25M	-$18M	-35.9%
Net Income	-$24M	-$18M	-30.4%

Revenue Segments

Product

$3M65%

Related Party

$1M33%

Service

$68,0002%